Liquidia Technologies Inc is trading 4.1% up today at $66.62 as investors respond to a series of upbeat analyst calls and rising price targets from major firms over recent days.
- Several analysts have issued updated Buy ratings with price targets now ranging between $67 and $75.
- The stock is maintaining strong momentum and attracting biotech traders focused on upcoming FDA decisions, even as the broader market faces weakness.